George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAGM.L Regulatory News (AGM)

  • There is currently no data for AGM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update

8 Jul 2022 15:55

RNS Number : 9016R
Applied Graphene Materials PLC
08 July 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("EUWA")) ("UK MAR"). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED WITHIN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF INSIDE INFORMATION (AS DEFINED UNDER UK MAR). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THOSE PERSONS THAT RECEIVED INSIDE INFORMATION IN A MARKET SOUNDING ARE NO LONGER IN POSSESSION OF SUCH INSIDE INFORMATION, WHICH IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

8 July 2022

Applied Graphene Materials plc

("Applied Graphene Materials", "the Group" or "the Company")

Update

 

The Company provides the following update.

 

The Company disclosed in its Annual Report and Accounts for the year ended 31 July 2021 that the Company has a cash runway beyond 31 January 2023.

 

In order to raise general awareness of the Company across the investment community ahead of any future equity raise, the Company has appointed Weild & Co acting via its representative Crestmont LLP. The purpose of Crestmont's appointment is to introduce the Company to new potential investors in non-UK jurisdictions but in particular focusing on the USA.

 

The Company appointed Weild & Co to effect these introductions on a general and non-deal specific basis with the process ongoing. The Board has been made aware that, as part of this non-deal process and without the Company's authority or instruction, disclosure has been made to certain of the third parties approached that the Company has engaged Crestmont in relation to an equity raise of up to $10 million.

 

In order to fund the Company's operations and continued development of the business beyond 31 January 2023, the Board confirms its intention to investigate a possible fundraise, quantum and timing to be determined but likely to be over the coming months.

 

The Company will make further announcements as appropriate.

 

 

For further information, please contact:

 

Applied Graphene Materials  +44 (0) 1642 438 214

Adrian Potts, Chief Executive Officer

David Blain, Chief Financial Officer

 

Singer Capital Markets  +44 (0) 207 496 3000

Peter Steel / Amanda Gray

 

Allenby Capital Limited  +44 (0) 203 328 5656

Nick Athanas / Liz Kirchner (Corporate Finance)

Matt Butlin / Kelly Gardiner (Sales and Corporate Broking)

 

Hudson Sandler +44 (0) 207 796 4133

Nick Lyon / Emily Dillon

 

 

Notes to Editors

 

Applied Graphene Materials  - For the last decade, AGM has been at the forefront of harnessing the possibilities of graphene. Founded originally by Professor Karl Coleman, the Group has grown from an academic idea from Durham University to a world leader in the development and application of graphene nanoplatelet dispersions for customers in the coatings, composites and functional materials sectors.

 

The Group utilises its proprietary bottom-up manufacturing process to produce high purity graphene nanoplatelets. Its expertise in dispersion chemistry enables AGM to create optimised, stable and easy to handle dispersions that customers use in real-world industrial products. AGM's unique approach enables industries to fully realise the potential of graphene in a simple, safe and easy to formulate way. 

 

AGM, based at the Wilton Centre on Teesside, was admitted to AIM in November 2013, raising £11 million. The Group successfully raised £8.5m in January 2016, £9.8m in November 2017 and a further £6m gross in January 2021. The Group's shares are also cross-traded on OTCQX in the United States. As a result of the funding support and its industry leading technology platform, AGM has been able to develop a significant sales distribution network covering Europe, North America and Asia. The Group continues to work closely with industrial partners, and has seen the successful launch of numerous commercial products enhanced by its Graphene Dispersions.

https://www.appliedgraphenematerials.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSSFFLAEESEIW
Date   Source Headline
30th Mar 20237:00 amRNSCorrection: Completion of Disposal
29th Mar 20237:00 amRNSCompletion of Disposal
28th Mar 20235:30 pmRNSApplied Graphene Materials
15th Mar 202312:35 pmRNSResult of General Meeting
27th Feb 20234:50 pmRNSPosting of Circular & Notice of General Meeting
22nd Feb 20237:00 amRNSProposed Disposal & Proposed Delisting
1st Feb 20237:30 amRNSSuspension - Applied Graphene Materials plc
26th Jan 20231:50 pmRNSUpdate on Annual Report and Accounts
13th Jan 20237:00 amRNSUpdate on Strategic Review & Other Matters
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
3rd Jan 20232:00 pmRNSPrice Monitoring Extension
29th Dec 20224:40 pmRNSSecond Price Monitoring Extn
29th Dec 20224:35 pmRNSPrice Monitoring Extension
28th Dec 20227:00 amRNSStrategic Review Update
23rd Nov 20224:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
23rd Nov 20229:05 amRNSSecond Price Monitoring Extn
23rd Nov 20229:00 amRNSPrice Monitoring Extension
23rd Nov 20227:00 amRNSStrategic Review
22nd Nov 20224:40 pmRNSSecond Price Monitoring Extn
22nd Nov 20224:35 pmRNSPrice Monitoring Extension
22nd Nov 20222:05 pmRNSSecond Price Monitoring Extn
22nd Nov 20222:00 pmRNSPrice Monitoring Extension
9th Nov 202211:06 amRNSSecond Price Monitoring Extn
9th Nov 202211:00 amRNSPrice Monitoring Extension
8th Nov 20222:06 pmRNSSecond Price Monitoring Extn
8th Nov 20222:00 pmRNSPrice Monitoring Extension
8th Nov 20228:09 amRNSUpdate
20th Sep 20224:40 pmRNSSecond Price Monitoring Extn
20th Sep 20224:35 pmRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSAGM Signs Agreement With Major Car Care Brand
30th Aug 20227:40 amEQSApplied Graphene Materials (AGM): Leading innovation with graphene dispersions
17th Aug 20222:06 pmRNSSecond Price Monitoring Extn
17th Aug 20222:00 pmRNSPrice Monitoring Extension
8th Jul 20224:40 pmRNSSecond Price Monitoring Extn
8th Jul 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20223:55 pmRNSUpdate
17th May 20227:00 amRNSExclusive agreement with Indian distributor
3rd May 20227:00 amRNSNew data package for chemical resistant coatings
6th Apr 20227:00 amRNSInterim Results
28th Mar 20227:00 amRNSInvestor Presentation
24th Mar 20227:00 amRNSNotice of interim results
15th Mar 20227:00 amRNSAGM signs agreement with Rayoung Chemtech
7th Feb 20227:00 amRNSAGM to show latest technology at coatings events
3rd Feb 20227:00 amRNSGraphene coating for power transmission assets
31st Jan 20223:54 pmRNSIssue of share options
17th Jan 20227:00 amRNSAGM coatings solutions used for EA flood defence
11th Jan 202211:36 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.